A familial outbreak of fascioliasis in Eastern Anatolia: A report with review of literature

Acta Tropica

Volumn 118, Issue 3, 2011, Pages 177-183

  Karahocagil, Mustafa Kasim ^a   Akdeniz, Hayrettin ^a   Sunnetcioglu, Mahmut ^a   Cicek, Muttalip ^a   Mete, Rafet ^a   Akman, Nevzat ^a   Ceylan, Ebubekir ^a   Karsen, Hasan ^a   Yapici, Kubilay ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Familial outbreak; Fasciola hepatica; Fascioliasis; Triclabendazole treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN E; PRAZIQUANTEL; PREDNISOLONE; TRICLABENDAZOLE;

DETECTION METHOD; DISEASE CONTROL; DISEASE TREATMENT; EPIDEMIOLOGY; HOSPITAL SECTOR; LITERATURE REVIEW; PARASITIC DISEASE; PEST OUTBREAK; TOMOGRAPHY;

ABDOMINAL PAIN; ADOLESCENT; ADULT; APPETITE DISORDER; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSPEPSIA; DYSPNEA; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EPIDEMIC; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL DISEASE; FASCIOLIASIS; FATIGUE; FECES ANALYSIS; FEMALE; FEVER; HEADACHE; HEPATOMEGALY; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; LYMPHADENOPATHY; MALAISE; MALE; MASS SCREENING; NAUSEA; PARASITE IDENTIFICATION; PRESCHOOL CHILD; PRURITUS; SCHOOL CHILD; SWEATING; URTICARIA; VOMITING; WATERCRESS; WEIGHT REDUCTION;

ABDOMEN; ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY HEALTH; FASCIOLA HEPATICA; FASCIOLIASIS; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; RADIOGRAPHY, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED; TURKEY; YOUNG ADULT;

ANATOLIA; TURKEY;

FASCIOLA HEPATICA; NASTURTIUM OFFICINALE;

EID: 79955599948     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.08.013     Document Type: Article

References (46)

1. Apt W., Aquilera X., Vega F., Miranda C., Zulantay I., Perez C., Gabor M., Apt P. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am. J. Trop. Med. Hyg. 1995, 52:532-535.
2. Bassily S., Iskander M., Youssef F.G., el-Masry N., Bawden M. Sonography in diagnosis of fascioliasis. Lancet 1989, 1:1270-1271.
3. Buyukbaba O., Ozkan E., Buyukuncu Y., Buget E. Fasciola hepatica'ya baĝli{dotless} bir kolesistit olgusu (A case of cholecystitis due to Fasciola hepatica). Klimik Derg. 1996, 9:98-99.
4. Cosme A., Ojeda E., Cilla G., Torrado J., Alzate L., Beristain X., Orive V., Arenas J. Fasciola hepatica. study of a series of 37 patients. Gastroenterol. Hepatol. 2001, 24:375-380.
5. Cumsudov C., Baydar B., Taner S., Sahin H., Demir A., Urhan M.K. Koledokta Fasciola hepatica: (Bir olgu nedeniyle). Turk. J. Gastroenterol. 1999, 10:164-166.
6. Danis M., Nozais J.P., Chandenier J. La distomatose à Fasciola hepatica II: La fasciolose humaine en France. Action Vet. 1985, 907:VII-VIII.
7. Demirci M., Korkmaz M., Kaya S., Kuman A. Fascioliasis in eosinophilic patients in the Isparta region of Turkey. Infection 2003, 31:15-18.
8. El-Morshedy H., Farghaly A., Sharaf S., Abou-Basha L., Barakat R. Triclabendazole in the treatment of human fascioliasis: a community-based study. East. Mediterr. Health J. 1999, 5:888-894.
9. Esteban J.G., Bargues M.D., Mas-Coma S. Geographgical distribution, diagnosis and treatment of human fascioliasis: a review. Res. Rev. Parasitol. 1998, 58:13-42.
10. Esteban J.G., Gonzalez C., Curtale F., Munoz-Antoli C., Valero M.A., Bargues M.D., El Sayed M., El Wakeel A., Abdel-Wahab Y., Montresor A., Engels D., Savioli L., Mas-Coma S. Hyperendemic fascioliasis associated with schistosomiasis in villages of the Nile Delta of Egypt. Am. J. Trop. Med. Hyg. 2003, 69:429-437.
11. Farag H.F., Barakat R.M., Ragab M., Omar E. A focus of human fascioliasis in the Nile Delta. Egypt. J. Trop. Med. Hyg. 1979, 82:188-190.
12. Farid Z., Trabolsi B., Boctor F., Hafez A. Unsuccessful use of Praziquantel to treat acute fascioliaisis in chi{dotless}ldren. J. Infect. Dis. 1986, 154:920-921.
13. Graham C.S., Brodie S.B., Weller P.F. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin. Infect. Dis. 2001, 33:1-5.
14. Guclu F., Dik B., Agaoglu M. Bir kadi{dotless}nda Fasciola hepatica'dan ileri gelen fascioliasis olgusu (A case of fascioliasis in a woman). Turk. Parazitol. Derg. 1995, 19:370-374.
15. Hawn T.R., Jong E.C. Update on hepatobiliary and pulmonary flukes. Curr. Infect. Dis. Rep. 1999, 1:427-433.
16. Hopkins D.R. Homing in on helminths. Am. J. Trop. Med. Hyg. 1992, 46:626-634.
17. Kabalioglu A., Apaydin A., Sindel T., Luleci E. US-guided gallbladder aspiration: a new diagnostic method for biliary fascioliasis. Eur. Radiol. 1999, 9:880-882.
18. Kabalioglu A., Cubuk M., Senol U., Cevikol C., Karaali K., Apaydin A., Sindel T., Luleci E. Fascioliasis: US CT and MRI findings with new observations. Abdom. Imaging 2000, 25:400-404.
19. Kabalioglu A., Ceken K., Saba R., Artan R., Cevikol C., Yilmaz S. Pediatric fascioliasis: report of three cases. Turk. J. Pediatr. 2003, 45:51-54.
20. Kaplan M., Kuk S., Kalkan A., Demirdag K., Ozdarendeli A. Fasciola hepatica seroprevalence in the Elazig region. Mikrobiyol. Bul. 2002, 36:337-342.
21. Kaya S., Demirci M., Demirel R., Aridogan B.C., Ozturk M., Korkmaz M. Seroprevalence of fascioliasis and the difference of fascioliasis between rural area and city center in Isparta, Turkey. Saudi Med. J. 2006, 27:1152-1156.
22. Knobloch J., Delgado E., Alvarez A., Reymann U., Bialek R. Human fascioliasis in Cajamarca/Peru I. Diagnostic methods and treatment with praziquantel. Trop. Med. Parasitol. 1985, 36:88-90.
23. Korkmaz M., Ok U.Z. Fasciolosis. Ozcel'in Tibbi Parazit Hastaliklari 2007, 499-518. Meta Basim, Izmir. M.A. Ozcel (Ed.).
24. MacLean J.D., Graeme-Cook F.M. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises; case 12-2002: a 50-year-old man with eosinophilia and fluctuating hepatic lesions. N. Engl. J. Med. 2002, 346:1232-1239.
25. Maguire J.H. Trematodes (Schistosomiasis) and other flukes. Principles and Practice of Infectious Diseases 2005, 3276-3285. Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
26. Mailles A., Capek I., Ajana F., Schepens C., Ilef D., Vaillant V. Commercial warecrees as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation. Epidemiol. Infect. 2006, 134:942-945.
27. Mas-Coma M.S., Esteban J.G., Bargues M.D. Epidemiology of human fascioliasis: a review and proposed new classification. Bull. World Health Organ. 1999, 77:340-346.
28. Mas-Coma S. Human fascioliasis. World Health Organisation (WHO). Waterborne Zoonoses: Identification Causes and Control 2004, 305-322. IWA Publishing, London. J.A. Cotruvo, A. Dufour, G. Rees, J. Bartram, R. Carr, D.O. Cliver, G.F. Craun, R. Fayer, V.P.J. Gannon (Eds.).
29. Mas-Coma S., Bargues M.D., Valero M.A. Fascioliasis and other plant-borne trematode zoonoses. Int. J. Parasitol. 2005, 35:1255-1278.
30. Nart D., Ertan Y., Doganavsargil B., Kilic M., Korkmaz M., Yuce G., Yilmaz F. Fascioliasis: üç olgu sunumu. Akademik Gastroenterol. Derg. 2005, 4:185-189.
31. O'Neill S.M., Parkinson M., Strauss W., Angles R., Dalton J.P. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L Cysteine proteinase. Am. J. Med. Hyg. 1998, 58:417-423.
32. Parkinson M., O'Neill S.M., Dalton J.P. Endemic human fascioliasis in the Bolivian Altiplano. Epidemiol. Infect. 2007, 135:669-674.
33. Price A., Tuazon C.U., Simon G.L. Fascioliasis. case reports and review. Clin. Infect. Dis. 1993, 17:426-430.
34. Pulpeiro J.R., Armesto V., Varela J., Corredoira J. Fascioliasis: findings in 15 patients. Br. J. Radiol. 1991, 64:798-801.
35. Rim H.J., Farag H.F., Sommani S., Cross J.H. Food-borne trematodes: ignored or emerging?. Parasitol. Today 1994, 10:207-209.
36. Rodríguez Hernández J., Canut Blasco A., Brezmes Valdivieso M.F., Martín Arribas M.I., Arias Paciencia M., Santana Rodríguez E., Martín Sánchez A.M. Familial outbreaks of fascioliasis: usefulness of serologic investigation by enzyme immunoassay. Rev. Clin. Esp. 1998, 198:33-35.
37. Rokni M.B., Massoud J., O'Neill S.M., Parkinson M., Dalton J.P. Diagnosis of human fascioliasis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn. Microbiol. Infect. Dis. 2002, 44:175-179.
38. Saba R., Korkmaz M., Inan D., Mamikoglu L., Turhan O., Gunseren F., Cevikol C., Kabaalioglu A. Human fascioliasis. Clin. Microbiol. Infect. 2004, 10:385-387.
39. Savioli L., Chistulo L., Montresor A. New opportunities for the control of fascioliasis. Bull. WHO 1999, 77:300.
40. Sezgin O., Altintas E., Disibeyaz S., Saritas U., Sahin B. Hepatobiliary fascioliasis clinical and radiologic features and endoscopic management. J. Clin. Gastroenterol. 2004, 38:285-290.
41. Tetik A., Turkkan I., Bilgen K., Yandakci K. Mekanik iktere neden olan beş Fasciola hepatica vakasi{dotless} (Five cases of Fasciola hepatica presenting with obstructive icterus). Klinik ve Deneysel Cerrahi Derg. 1995, 3:229.
42. Tolan Jr., R.W., 2008. eMedicine. Fascioliasis. Available at http://www.emedicine.com/ped/topc760.htm.
43. Truant A., Elliot S.H., Kelly M.T., Smith J.H. Comparison of formalin-ethyl ether sedimentation, formalin-ethyl acetate sedimentation, and zinc sulfate flotation techniques for detection of intestinal parasites. J. Clin. Microbiol. 1981, 13:882-884.
44. Turhan O., Korkmaz M., Saba R., Kabaaalioglu A., Inan D., Mamikoglu L. Seroepidemiology of fascioliasis in the Antalya region and uselessness of eosinophil count as a surrogate marker and portable ultrasonography for epidemiological surveillance. Infez. Med. 2006, 14:208-212.
45. Wesseley K., Reischig H.L., Heinerman M., Stempka R. Human fascioliasis treated with triclabendazole (Fasinex) for the first time. Trans. R. Soc. Trop. Med. Hyg. 1988, 82:743-745.
46. Yilmaz H., Gokmerdan A. Human fascioliasis in Van province, Turkey. Acta Trop. 2004, 92:161-162.